Search BRITE hierarchies

Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
  A ALIMENTARY TRACT AND METABOLISM
    A04 ANTIEMETICS AND ANTINAUSEANTS
      A04A ANTIEMETICS AND ANTINAUSEANTS
        A04AD Other antiemetics
          A04AD01 Scopolamine [DG:DG00065]
            D00138  Scopolamine (INN) <US>
  N NERVOUS SYSTEM
    N05 PSYCHOLEPTICS
      N05C HYPNOTICS AND SEDATIVES
        N05CM Other hypnotics and sedatives
          N05CM05 Scopolamine [DG:DG00065]
            D00138  Scopolamine (INN) <US>
  S SENSORY ORGANS
    S01 OPHTHALMOLOGICALS
      S01F MYDRIATICS AND CYCLOPLEGICS
        S01FA Anticholinergics
          S01FA02 Scopolamine [DG:DG00065]
            D00138  Scopolamine (INN) <US>

USP drug classification [BR:br08302]
  Antiemetics
    Antiemetics, Other
      Scopolamine [DG:DG00065]
        D00138  Scopolamine (INN)
  Gastrointestinal Agents
    Antispasmodics, Gastrointestinal
      Scopolamine [DG:DG00065]
        D00138  Scopolamine (INN)

Risk category of Japanese OTC drugs [BR:br08312]
  Second-class OTC drugs
    Inorganic and organic chemicals
      Scopolamine
        D00138  Scopolamine (INN)

Drug groups [BR:br08330]
  Neuropsychiatric agent
    DG01491  Muscarinic cholinergic receptor antagonist
      DG00065  Scopolamine
        D00138  Scopolamine
  Gastrointestinal agent
    DG01762  Antiemetic
      DG00065  Scopolamine
        D00138  Scopolamine

Target-based classification of drugs [BR:br08310]
  G Protein-coupled receptors
    Rhodopsin family
      Acetylcholine (muscarinic)
        CHRM [HSA:1128 1129 1131 1132 1133] [KO:K04129 K04130 K04131 K04132 K04133]
          D00138  Scopolamine (INN) <US>

[ BRITE | KEGG2 | KEGG ]